Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 135

1.

Tetrakis(1,2,5-thiadiazolo)porphyrazines. 9. Synthesis and spectral and theoretical studies of the lithium(i) complex and its unusual behaviour in aprotic solvents in the presence of acids.

Stuzhin PA, Ivanova SS, Hamdoush M, Kirakosyan GA, Kiselev A, Popov A, Sliznev V, Ercolani C.

Dalton Trans. 2019 Sep 6. doi: 10.1039/c9dt02345c. [Epub ahead of print]

PMID:
31490491
2.

Carbon Supported Gold Nanoparticles for the Catalytic Reduction of 4-Nitrophenol.

Rodríguez Molina H, Santos Muñoz JL, Domínguez Leal MI, Reina TR, Ivanova S, Centeno Gallego MÁ, Odriozola JA.

Front Chem. 2019 Aug 16;7:548. doi: 10.3389/fchem.2019.00548. eCollection 2019.

3.

Identification and quantification of phenolic compounds of Western Siberia Astragalus danicus in different regions.

Babich O, Prosekov A, Zaushintsena A, Sukhikh A, Dyshlyuk L, Ivanova S.

Heliyon. 2019 Aug 10;5(8):e02245. doi: 10.1016/j.heliyon.2019.e02245. eCollection 2019 Aug.

4.

Therapeutic drug monitoring of olanzapine and cytochrome P450 genotyping in non-smoking subjects.

Miroshnichenko II, Pozhidaev IV, Ivanova SA, Baymeeva NV.

Ther Drug Monit. 2019 Aug 14. doi: 10.1097/FTD.0000000000000695. [Epub ahead of print]

PMID:
31425442
5.

Au/CeO2-ZnO/Al2O3 as Versatile Catalysts for Oxidation Reactions: Application in Gas/Liquid Environmental Processes.

Megías-Sayago C, Reina TR, Ivanova S, Odriozola JA.

Front Chem. 2019 Jul 12;7:504. doi: 10.3389/fchem.2019.00504. eCollection 2019.

6.

Apolipoprotein serum levels related to metabolic syndrome in patients with schizophrenia.

Boiko AS, Mednova IA, Kornetova EG, Semke AV, Bokhan NA, Loonen AJM, Ivanova SA.

Heliyon. 2019 Jul 3;5(7):e02033. doi: 10.1016/j.heliyon.2019.e02033. eCollection 2019 Jul.

7.

The difference in serum proteomes in schizophrenia and bipolar disorder.

Smirnova L, Seregin A, Boksha I, Dmitrieva E, Simutkin G, Kornetova E, Savushkina O, Letova A, Bokhan N, Ivanova S, Zgoda V.

BMC Genomics. 2019 Jul 11;20(Suppl 7):535. doi: 10.1186/s12864-019-5848-1.

8.

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial.

Heerspink HJL, Parving HH, Andress DL, Bakris G, Correa-Rotter R, Hou FF, Kitzman DW, Kohan D, Makino H, McMurray JJV, Melnick JZ, Miller MG, Pergola PE, Perkovic V, Tobe S, Yi T, Wigderson M, de Zeeuw D; SONAR Committees and Investigators.

Lancet. 2019 May 11;393(10184):1937-1947. doi: 10.1016/S0140-6736(19)30772-X. Epub 2019 Apr 14. Erratum in: Lancet. 2019 May 11;393(10184):1936.

PMID:
30995972
9.

Powder and Nanotubes Titania Modified by Dye Sensitization as Photocatalysts for the Organic Pollutants Elimination.

Murcia JJ, Ávila-Martínez EG, Rojas H, Cubillos J, Ivanova S, Penkova A, Laguna OH.

Nanomaterials (Basel). 2019 Apr 2;9(4). pii: E517. doi: 10.3390/nano9040517.

10.

A pharmacogenetic study of patients with schizophrenia from West Siberia gets insight into dopaminergic mechanisms of antipsychotic-induced hyperprolactinemia.

Osmanova DZ, Freidin MB, Fedorenko OY, Pozhidaev IV, Boiko AS, Vyalova NM, Tiguntsev VV, Kornetova EG, Loonen AJM, Semke AV, Wilffert B, Bokhan NA, Ivanova SA.

BMC Med Genet. 2019 Apr 9;20(Suppl 1):47. doi: 10.1186/s12881-019-0773-3.

11.

Consider Role of Glutamatergic Habenula-projecting Globus Pallidus in OCD.

Loonen AJM, Ivanova SA.

Pharmacopsychiatry. 2019 Jul;52(4):203-204. doi: 10.1055/a-0835-6447. Epub 2019 Feb 4.

PMID:
30716772
12.

Opening up new horizons for psychiatric genetics in the Russian Federation: moving toward a national consortium.

Fedorenko OY, Golimbet VE, Ivanova SА, Levchenko А, Gainetdinov RR, Semke AV, Simutkin GG, Gareeva АE, Glotov АS, Gryaznova A, Iourov IY, Krupitsky EM, Lebedev IN, Mazo GE, Kaleda VG, Abramova LI, Oleichik IV, Nasykhova YA, Nasyrova RF, Nikolishin AE, Kasyanov ED, Rukavishnikov GV, Timerbulatov IF, Brodyansky VM, Vorsanova SG, Yurov YB, Zhilyaeva TV, Sergeeva AV, Blokhina EA, Zvartau EE, Blagonravova AS, Aftanas LI, Bokhan NА, Kekelidze ZI, Klimenko TV, Anokhina IP, Khusnutdinova EK, Klyushnik TP, Neznanov NG, Stepanov VA, Schulze TG, Kibitov АО.

Mol Psychiatry. 2019 Aug;24(8):1099-1111. doi: 10.1038/s41380-019-0354-z. Epub 2019 Jan 21. Review.

PMID:
30664668
13.

SIRT1 Allele Frequencies in Depressed Patients of European Descent in Russia.

Aftanas LI, Anisimenko MS, Berdyugina DA, Garanin AY, Maximov VN, Voevoda MI, Vyalova NM, Bokhan NA, Ivanova SA, Danilenko KV, Kovalenko SP.

Front Genet. 2019 Jan 4;9:686. doi: 10.3389/fgene.2018.00686. eCollection 2018.

14.

Pharmacogenetics of tardive dyskinesia in schizophrenia: The role of CHRM1 and CHRM2 muscarinic receptors.

Boiko AS, Ivanova SA, Pozhidaev IV, Freidin MB, Osmanova DZ, Fedorenko OY, Semke AV, Bokhan NA, Wilffert B, Loonen AJM.

World J Biol Psychiatry. 2019 Jan 9:1-6. doi: 10.1080/15622975.2018.1548780. [Epub ahead of print]

PMID:
30623717
15.

No evidence so far of a major role of AKT1 and GSK3B in the pathogenesis of antipsychotic-induced tardive dyskinesia.

Levchenko A, Vyalova N, Pozhidaev IV, Boiko AS, Osmanova DZ, Fedorenko OY, Semke AV, Bokhan NA, Wilffert B, Loonen AJM, Ivanova SA.

Hum Psychopharmacol. 2019 Jan;34(1):e2685. doi: 10.1002/hup.2685. Epub 2019 Jan 8.

PMID:
30623492
16.

Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.

Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, Doyle RT Jr, Juliano RA, Jiao L, Granowitz C, Tardif JC, Ballantyne CM; REDUCE-IT Investigators.

N Engl J Med. 2019 Jan 3;380(1):11-22. doi: 10.1056/NEJMoa1812792. Epub 2018 Nov 10.

PMID:
30415628
17.

The evolutionary old forebrain as site of action to develop new psychotropic drugs.

Loonen AJ, Ivanova SA.

J Psychopharmacol. 2018 Dec;32(12):1277-1285. doi: 10.1177/0269881118798617. Epub 2018 Sep 26.

18.

Sulfonylurea Receptor 1, Transient Receptor Potential Cation Channel Subfamily M Member 4, and KIR6.2:Role in Hemorrhagic Progression of Contusion.

Gerzanich V, Stokum JA, Ivanova S, Woo SK, Tsymbalyuk O, Sharma A, Akkentli F, Imran Z, Aarabi B, Sahuquillo J, Simard JM.

J Neurotrauma. 2019 Apr 1;36(7):1060-1079. doi: 10.1089/neu.2018.5986. Epub 2018 Oct 4.

19.

Autoimmunity and immune system dysregulation in schizophrenia: IgGs from sera of patients hydrolyze myelin basic protein.

Parshukova D, Smirnova LP, Ermakov EA, Bokhan NA, Semke AV, Ivanova SA, Buneva VN, Nevinsky GA.

J Mol Recognit. 2019 Feb;32(2):e2759. doi: 10.1002/jmr.2759. Epub 2018 Aug 15.

PMID:
30112774
20.

Polymorphisms of Catechol-O-Methyl Transferase (COMT) Gene in Vulnerability to Levodopa-Induced Dyskinesia.

Ivanova SA, Alifirova VM, Pozhidaev IV, Freidin MB, Zhukova IA, Osmanova DZ, Zhukova NG, Mironova YA, Tiguntsev VV, Fedorenko OY, Bokhan NA, Wilffert B, Loonen AJM.

J Pharm Pharm Sci. 2018;21(1):340-346. doi: 10.18433/jpps29903.

Supplemental Content

Loading ...
Support Center